NASDAQ: ASBP
Aspire Biopharma Holdings Inc Stock Ownership - Who owns Aspire Biopharma Holdings?

Insider buying vs selling

Have Aspire Biopharma Holdings Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ASBP insiders and whales buy or sell their stock.

ASBP Shareholders

What type of owners hold Aspire Biopharma Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Surendra K. Ajjarapu8.83%4,317,500$2.03MInsider
Powerup Sponsor LLC5.87%2,870,000$1.35MInsider
Harraden Circle Investments LLC0.92%449,783$211.40kInstitution
Clear Street LLC0.05%22,852$10.74kInstitution
Osaic Holdings Inc0.00%100$47.00Institution
Ubs Group Ag0.00%45$21.15Institution
Farther Finance Advisors LLC0.00%20$9.40Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

ASBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ASBP0.97%14.70%
LSTA0.89%99.11%Net Selling
ALLR0.61%11.67%Net Buying
LEXX8.21%3.91%Net Buying
CALC14.43%85.57%Net Buying

Aspire Biopharma Holdings Stock Ownership FAQ

Who owns Aspire Biopharma Holdings?

Aspire Biopharma Holdings (NASDAQ: ASBP) is owned by 0.97% institutional shareholders, 14.70% Aspire Biopharma Holdings insiders, and 84.34% retail investors. Surendra K. Ajjarapu is the largest individual Aspire Biopharma Holdings shareholder, owning 4.32M shares representing 8.83% of the company. Surendra K. Ajjarapu's Aspire Biopharma Holdings shares are currently valued at $1.83M.

If you're new to stock investing, here's how to buy Aspire Biopharma Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.